X
About Us

About Venus MedTech

Venus Medtech (Hangzhou) Inc. ("Venus Medtech"), is the leader in transcatheter structural heart valvular therapies in China. The company is committed to the development and commercialization of innovative medical devices in the field of structural heart disease.

Venus Medtech is founded in 2009 and headquartered in Hangzhou National High-Tech Industrial Development Zone (Binjiang). In 2014, the New Bioprosthetic Aortic Valve Project gained Venus Medtech a national champion in the biomedicine sector and brought the company to prominence. The impressive progress of the company is marked by multiple industry-first achievements: the first company to receive NMPA approval for its TAVR product, the first company to develop TAVR product with retrievable function, the first company to receive NMPA approval for its TPVR product, the first created-in-China heart valve device to obtain CE marking, and the first company approved to establish a heart valve research institute in China. On December 10th, 2019, the company was successfully listed on the Main Board of the Hong Kong Stock Exchange (stock code: 2500.HK).

Venus Medtech has established comprehensive solutions for structural heart disease, with a complete product pipeline covering all four heart valves, namely TAVR, TPVR, TMVR and TTVR, as well as hypertrophic cardiomyopathy, hypertensive renal denervation (RDN) therapy and relevant accessory products.

As of December 2023, Venus Medtech had a total of 800+ patents and patents under application, including 400+ authorized invention patents. Our global intellectual property portfolio covers China, United States, Europe, Japan, Canada, Russia, India, Brazil and other countries and regions. As an innovative Chinese enterprise, Venus Medtech enjoys a wealth of awards and honors, including undertaking the National Science and Technology Support Program under the 12th Five-Year Development Plan and National Key Research and Development Program under the 13th Five-Year Development Plan initiated by the Ministry of Science and Technology of China, the second batch of State-Level Technologically Advanced Little Giant Enterprises, China Outstanding Patent Award, Excellent Domestic Medical Equipment Products, and National High-Tech Enterprise.

Moving Forward, Venus Medtech will focus on new materials, bionics, image fusion techniques and digital sensing for continuous upgrades and innovation, meeting the needs of doctors and patients worldwide. As a leading company in the field of heart valve, we aim to motivate and inspire innovators in China’s healthcare sector with our path to development. Innovation drives the future. At Venus Medtech, we will continue our efforts to develop and commercialize novel structural heart devices, supporting China’s rise as an innovation powerhouse and contributing to the well-being of global communities.

Founder's Profile

Our Team

  • Zeng Min

    Mr. ZENG Min is Co-founder of Venus Medtech. Mr. Zeng has more than 20 years of experience in the medical device industry. He received BS in Solid Mechanics from Tsinghua University, China, in July 1986 and MS in Engineering from the University of Texas at Austin, United States, in August 1994.

  • Eric Zi

    Mr. Eric ZI is Co-founder of Venus Medtech. Mr. Zi has more than 20 years of experience in the medical device industry. He is the main designer of China's first-generation PTCA balloon, coronary stent, aortic aneurysm stent, and left atrial appendage occluder. He developed the first generation of congenital heart disease interventional occluder and inferior vena cava thrombus filter products in China, and introduced to international markets.

Company Honor

Select year：

  • Excellent R&D Team

       Jun 2021— Hangzhou Municipal New Economic and New Social Organizations Working Committee, Hangzhou Digital Economy Comprehensive Committee

  • First Prize of the Technical Invention Award of the Excellent Achievements in Scientific Research (Science and Technology) of Higher Education

       Mar 2021— Ministry of Education

  • Key Laboratory for Quality Research and Control of Tissue Regeneration Biomaterials

       Feb 2021— National Medical Products Administration (NMPA)

  • 2020 Zhejiang Province Trademark Brand Strategy Demonstration Enterprise

       Jan 2021— Zhejiang Provincial Administration for Market Regulation

  • 2020 China Big Health Industry Trend List - Excellence Enterprise of the Medical Device

       Jan 2021— 21st Century Business Herald

  • The 5th Annual Golden Hong Kong Stock Awards - Best Pharmaceutical and Medical Company

       Jan 2021— Zhitong Finance, Tonghuashun Finance

  • 2020 Hangzhou Patent Pilot Enterprise

       Nov 2020— Hangzhou Municipal Administration of Market Regulation

  • Second Batch of State-Level Technologically Advanced Little Giant Enterprises

       Nov 2020— Office of Small and Medium-sized Enterprises, Ministry of Industry and Information Technology

  • 2020 Top 500 New Economy Enterprise in China

       Nov 2020— China Enterprise Evaluation Association

  • 2020 Excellent Industrial Product in Zhejiang Province

       Sep 2020— Zhejiang Excellent Industrial Products Selection Committee

  • Excellent Domestic Medical Equipment Products

       Sep 2020— China Association of Medical Equipment

  • China Patent Excellence Award

       Jul 2020— China National Intellectual Property Administration

  • 3rd Phoenix Award for Top 10 IPOs in Zhejiang Province

       Mar 2020— Zhejiang Investment and M&A Association

  • 2019 Gazelle Company

       Mar 2020— Hangzhou High-tech Development Zone (Binjiang) Bureau of Economy and Information Technology

  • Sichuan Provincial Science and Technology Progress Award (Development and popularization of transcatheter aortic valve implantation device)

       Feb 2020— Sichuan Provincial People's Government

  • 2020 Top 50 Private Enterprises for Multinational Operations in Zhejiang

       Jan 2020— Zhejiang Institute of Multinational Corporations, Zhejiang Outbound Investment Enterprises Association

  • National High-Tech Enterprise

       Dec 2019— Science Technology Department of Zhejiang Province

  • Zhejiang Provincial Key Laboratory for Implantable and Interventional Right Heart Devices

       Nov 2019— Science Technology Department of Zhejiang Province

  • 2018 Gazelle Company

       Jul 2019— Hangzhou High-tech Development Zone (Binjiang) Bureau of Economy and Information Technology

  • Well-Known Trademark in Zhejiang

       Jan 2019— Zhejiang Provincial Administration for Market Regulation

  • Engineering Research Center for Functional Materials for Cardiovascular Applications in Zhejiang Province

       Jan 2019— Zhejiang Provincial Development and Reform Commission

  • Hangzhou Enterprise Technology Center

       Jan 2019— Hangzhou Science and Technology Bureau

  • Leading Medical Devices Brand in China

       Sep 2018— Office of China Consumption and Economy Forum, Consumption Daily

  • National Science and Technology Support Program Award under the 13th Five-Year Development Plan

       Apr 2017— Ministry of Science and Technology of China

  • Leading Team for Innovation and Entrepreneurship

       Apr 2016— Science Technology Department of Zhejiang Province

  • Key Enterprise Research Institute for TVR Product Development Project

       Apr 2014— Science Technology Department of Zhejiang Province

  • National Science and Technology Support Program Award under the 12th Five-Year Development Plan

       Apr 2014— Ministry of Science and Technology of China

  • Champion in Biomedicine, 3rd China Innovation and Entrepreneurship Competition

       Apr 2014— Ministry of Science and Technology of China

  • Excellent R&D Team

    Jun 2021 — Hangzhou Municipal New Economic and New Social Organizations Working Committee, Hangzhou Digital Economy Comprehensive Committee

  • First Prize of the Technical Invention Award of the Excellent Achievements in Scientific Research (Science and Technology) of Higher Education

    Mar 2021 — Ministry of Education

  • Key Laboratory for Quality Research and Control of Tissue Regeneration Biomaterials

    Feb 2021 — National Medical Products Administration (NMPA)

  • 2020 Zhejiang Province Trademark Brand Strategy Demonstration Enterprise

    Jan 2021 — Zhejiang Provincial Administration for Market Regulation

  • 2020 China Big Health Industry Trend List - Excellence Enterprise of the Medical Device

    Jan 2021 — 21st Century Business Herald

  • The 5th Annual Golden Hong Kong Stock Awards - Best Pharmaceutical and Medical Company

    Jan 2021 — Zhitong Finance, Tonghuashun Finance

  • 2020 Hangzhou Patent Pilot Enterprise

    Nov 2020 — Hangzhou Municipal Administration of Market Regulation

  • Second Batch of State-Level Technologically Advanced Little Giant Enterprises

    Nov 2020 — Office of Small and Medium-sized Enterprises, Ministry of Industry and Information Technology

  • 2020 Top 500 New Economy Enterprise in China

    Nov 2020 — China Enterprise Evaluation Association

  • 2020 Excellent Industrial Product in Zhejiang Province

    Sep 2020 — Zhejiang Excellent Industrial Products Selection Committee

  • Excellent Domestic Medical Equipment Products

    Sep 2020 — China Association of Medical Equipment

  • China Patent Excellence Award

    Jul 2020 — China National Intellectual Property Administration

  • 3rd Phoenix Award for Top 10 IPOs in Zhejiang Province

    Mar 2020 — Zhejiang Investment and M&A Association

  • 2019 Gazelle Company

    Mar 2020 — Hangzhou High-tech Development Zone (Binjiang) Bureau of Economy and Information Technology

  • Sichuan Provincial Science and Technology Progress Award (Development and popularization of transcatheter aortic valve implantation device)

    Feb 2020 — Sichuan Provincial People's Government

  • 2020 Top 50 Private Enterprises for Multinational Operations in Zhejiang

    Jan 2020 — Zhejiang Institute of Multinational Corporations, Zhejiang Outbound Investment Enterprises Association

  • National High-Tech Enterprise

    Dec 2019 — Science Technology Department of Zhejiang Province

  • Zhejiang Provincial Key Laboratory for Implantable and Interventional Right Heart Devices

    Nov 2019 — Science Technology Department of Zhejiang Province

  • 2018 Gazelle Company

    Jul 2019 — Hangzhou High-tech Development Zone (Binjiang) Bureau of Economy and Information Technology

  • Well-Known Trademark in Zhejiang

    Jan 2019 — Zhejiang Provincial Administration for Market Regulation

  • Engineering Research Center for Functional Materials for Cardiovascular Applications in Zhejiang Province

    Jan 2019 — Zhejiang Provincial Development and Reform Commission

  • Hangzhou Enterprise Technology Center

    Jan 2019 — Hangzhou Science and Technology Bureau

  • Leading Medical Devices Brand in China

    Sep 2018 — Office of China Consumption and Economy Forum, Consumption Daily

  • National Science and Technology Support Program Award under the 13th Five-Year Development Plan

    Apr 2017 — Ministry of Science and Technology of China

  • Leading Team for Innovation and Entrepreneurship

    Apr 2016 — Science Technology Department of Zhejiang Province

  • Key Enterprise Research Institute for TVR Product Development Project

    Apr 2014 — Science Technology Department of Zhejiang Province

  • National Science and Technology Support Program Award under the 12th Five-Year Development Plan

    Apr 2014 — Ministry of Science and Technology of China

  • Champion in Biomedicine, 3rd China Innovation and Entrepreneurship Competition

    Apr 2014 — Ministry of Science and Technology of China
XML 地图